It was found that knockdown of AURKA significantly decreased growth of ES cells in vitro and in vivo, in line with previous reports that AURKA acts as an oncogene in various cancers, including gastric cancer, rhabdomyosarcoma, and colorectal cancer [31, 32]. This evidence concerns the gene AURKA and rhabdomyosarcoma.